|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 8, 2016
ABBVIE INC.
(Exact... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Files Form 8-K
NORTH CHICAGO, ILLINOIS, U.S.A., June 8, 2016 - AbbVie Inc. ("AbbVie") (NYSE /
CHX / Euronext Paris / SIX: ABBV) today informs its stockholders that it has
filed a Periodic Report on Form 8-K with the U.S. Securities and Exchange
Commission ("SEC") regarding a blackout period for AbbVie retirement plan.
AbbVie makes available free of charge on its website, its... Lire le communiqué |
|
| |
|
| |
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 1, 2016
ABBVIE INC.
(Exact name of... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Files Form 8-K
NORTH CHICAGO, ILLINOIS, U.S.A., June 2, 2016 - AbbVie Inc. ("AbbVie") (NYSE /
CHX / Euronext Paris / SIX: ABBV) today informs its stockholders that it has
filed a Periodic Report on Form 8-K with the U.S. Securities and Exchange
Commission ("SEC") regarding the share repurchase related to the Stemcentrx
acquisition.
AbbVie makes available free of charge on its... Lire le communiqué |
|
| |
|
| |
|
|
PRESS RELEASE
AbbVie Files Form 8-K
NORTH CHICAGO, ILLINOIS, U.S.A., June 1, 2016 - AbbVie Inc. ("AbbVie") (NYSE /
CHX / Euronext Paris / SIX: ABBV) today informs its stockholders that it has
filed a Periodic Report on Form 8-K with the U.S. Securities and Exchange
Commission ("SEC") announcing the completion of its acquisition of
Stemcentrix.
AbbVie makes available free of charge... Lire le communiqué |
|
| |
|
| |
|
|
AbbVie Files Form 8-K
NORTH CHICAGO, ILLINOIS, U.S.A., May 12, 2016 - AbbVie Inc. ("AbbVie") (NYSE /
CHX / Euronext Paris / SIX: ABBV) today informs its stockholders that it has
filed a Periodic Report on Form 8-K with the U.S. Securities and Exchange
Commission ("SEC") announcing the issuance and sale of debt securities.
AbbVie makes available free of charge on its website, its Annual... Lire le communiqué |
|
| |
|
| |
|
|
Use these links to rapidly review the document
TABLE OF CONTENTS
TABLE OF CONTENTS
Filed Pursuant to Rule 424b5
Reg i stra ti o n No. 333203677
... Lire le communiqué |
|
| |
|
| |
